Skip to main content
Top
Gepubliceerd in: Quality of Life Research 1/2023

Open Access 29-08-2022

Sex differences in quality of life of patients following percutaneous coronary intervention in Vietnam

Auteurs: Hoa Vu, Richard Norman, Ngoc M. Pham, Hoai T. T. Nguyen, Hung M. Pham, Quang N. Nguyen, Loi D. Do, Christopher M. Reid

Gepubliceerd in: Quality of Life Research | Uitgave 1/2023

Abstract

Purpose

Data regarding the health-related quality of life (HRQoL) in men and women after percutaneous coronary intervention (PCI) in low-and-middle incomes countries remains scarce. To investigate sex difference in the HRQoL at 30 days and 12 months post PCI in Vietnam.

Methods

We used data from a single percutaneous coronary registry established in the Vietnam National Heart Institute. The HRQoL was measured using the EQ-5D-3L instrument via telephone interviews, and information about demographics, clinical presentation and procedures was obtained through face-to-face interviews and medical records. The HRQoL between men and women were compared using independent samples t tests, the Mann–Whitney U test or univariate/multivariate logistic regression.

Results

There were 866 patients included in this cohort, with the proportion of women being nearly half of men (32.1 vs 67.9%). Women were 3.5 years older, had lower income and educational levels but greater prevalence of cardiovascular risk factors. At 30 days, women significantly had more problems in mobility, personal care and pain/discomfort compared to men. At 12 months, women had more problem than men in usual activity. The geometric means of HRQoL was lower in women at 30 days, but not in 12 months. From 30 days to 12 months after discharge, women showed better recovery in mobility compared to men, but not in other dimensions.

Conclusions

In this first insight of sex differences in HRQoL following PCI in Vietnam, women appeared to have worse quality of life, especially at 30 days after discharge but they showed better recovery in mobility at 12 months compared to men.
Opmerkingen

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1007/​s11136-022-03237-5.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Afkortingen
ACS
Acute coronary syndrome
AMI
Acute myocardial infarction
CABG
Coronary artery bypass grafts
CHD
Coronary heart disease
HRQOL
Health related Quality of Life
NSTEMI
Non-ST-elevation myocardial infraction
PCI
Percutaneous coronary intervention
STEMI
ST-elevation myocardial infraction
UA
Unstable angina
VNHI
Vietnam National Heart Institute

Introduction

Studies regarding the effectiveness of medical treatments and patient recovery from cardiac interventions have attracted growing interest. While mortality and objective measures of morbidity are traditionally considered key clinical outcome measures, health-related quality of life (HRQoL) has been increasingly utilized in contemporary research due to its capability to provide patient-reported outcomes covering both symptoms and the functional impact of the illness and its treatments [13]. Patients therefore provide their own perspectives in defining health status, both in terms of how they feel (distress and well-being) and how they evaluate their own health and future prospects [4, 5].
Sex differences in clinical outcomes after percutaneous coronary intervention (PCI) have been widely documented in current literature, and typically suggest that women have worse post procedural outcomes than men (e.g., higher mortality and morbidity rates) [611]. Among studies that have addressed the gender differences in HRQoL outcomes after PCI, the majority of them have observed poorer post-procedure HRQoL in women patients, especially in the short and medium-term [7, 8, 1214], while some publications reported no significant differences between the sexes in HRQoL in the long-term post procedure (3 and 10 years) [6, 12]. Explanations for the sex differences in outcomes in these studies include biological factors such as age and cardiovascular risk factors, and social factors such as social support and health care access [7, 15]. However, such findings are inevitably context-specific, meaning it remains unclear that such explanations can be applied into different populations and cultures. Hence, more comprehensive studies are required to explore this aspect, especially in limited resources countries where the health of women is often prioritised less than that of men.
Our study is the first to utilize data from a PCI registry in Vietnam to examine the HRQoL between men and women at 30 days and 12 months post discharge.

Method

Study setting

This study uses data from a PCI registry conducted from September 2017 to May 2018 in Vietnam National Heart Institute (VNHI), Hanoi, Vietnam. Details of the PCI registry have been previously described [1619]. Briefly, the pilot hospital-based registry adapted the data collection forms from a long-standing registry in Australia to collect information on demographic, clinical and procedural information, and outcomes of patients who underwent PCI at VNHI [20, 21]. After discharge from the index PCI, patients were followed up at 30 days and 12 months for information about their health status and quality of life. Data were collected through interviewing patients, extracting medical records and reading secured disks at baseline. At follow-up visits, data collection was conducted via face-to-face and supplemented with telephone interviews. Ethics approval was obtained from the Curtin Human Research Ethics Committee before the commencement of data collection (HRE 2017-0378). Patients were aware of the right to opt out from the study without any treatment impact. A team of specifically trained local investigators at VNHI was responsible for data collection.
The study captured 1022 patients from the PCI registry. For the purpose of HRQoL analysis, all patients who had data available and were alive 12 months after the index PCI were included in this study. Those with missing HRQoL data at 30 days (n = 43) and 12 months (n = 53) and those had died in the 1 year subsequent to hospital discharge (n = 60) were excluded. Essential characteristics between participants who were lost to follow-up (n = 96) and those who were not (n = 866) were compared and found that the characteristics between two groups are similar with the exception of age. Therefore, eliminating 96 patients lost to follow-up was unlikely to significantly affect the results reported in the paper. A final sample of 866 patients remained for the present analysis.

Quality of life at 30 days and 12 months

The primary endpoint was patients’ HRQoL at 30 days and 12 months according to sex. HRQoL was assessed using the EQ-5D-3L, an instrument for health status measurement developed by the Euro HRQoL group [22]. The EQ-5D-3L is composed of the following dimensions: mobility; personal care; usual activities; pain/discomfort; and anxiety/depression. Each dimension has three response levels: no, some or extreme problems (e.g., unable to walk, extreme pain/discomfort). There are 243 theoretically possible health status of patients in the EQ-5D-3L, in which each health status is referred to as a health state. Each patient response to the EQ-5D-3L was converted to an index score, using the Malaysian value set. Vietnam does not have a value set for the instrument, and we selected the Malaysian data due to the geographic, socioeconomic and cultural similarity between the Malaysian and Vietnamese populations [23]. The higher EQ-5D-3L score indicates the higher health status for patients. Additionally, patients were asked to provide a self-rating health status based on a scale of 0–100, the EQ-Visual Analogue Scale (VAS), in which a higher score indicated better self-assessed health. The change in HRQoL of patients from 30 days to 12 months were calculated based on their answers of HRQoL at two follow-ups and categorised into “no change”, “get worse”, and “get better”. Get better was defined if a patient reported better health status at 12 months in comparison with 30 days (extreme/some problems to no problems; extreme to some problems). Get worse was defined if a patient claimed worse health status at 12 months compared to that at 30 days (no problem to some or extreme problems; some problems to extreme problems).

Clinical presentations

ST-elevation myocardial infarction (STEMI) was defined as the elevation of cardiac biomarkers and new or presumed new ST-segment elevation in two or more contiguous ECG leads. Non-ST-elevation myocardial infarction (NSTEMI) was diagnosed in the presence of elevated cardiac biomarkers and at least one of either, changes in ECG (ST-segment depression or T wave abnormalities) or ischemic symptoms [24]. Unstable angina (UA) was identified in the presence of prolonged chest pain without cardiac enzyme elevation [25].
The strategy for the specific coronary intervention (e.g., choice of entry location, stent, medication) was at the discretion of the interventionists. Injured lesion segments were identified and coded following the definition of the coronary tree segments developed in the SYNTAX study (26) and guidelines for the lesion type of the American College of Cardiology/American Heart Association (ACC/AHA) [27]. A procedure was considered successful if there was a residual stenosis of less than 10% following coronary stenting and the rate of coronary blood perfusion of Thrombosis in Myocardial Infarction (TIMI) 2 or 3 flow. Bleeding was classified by the Bleeding Academic Research Consortium (BARC) criteria [28], while major bleeding was defined by any transfusion or by a drop-in haemoglobin ≥ 3.0 g/dl.

Statistical analysis

Categorical data on baseline and procedural characteristics between men and women were presented as numbers and percentages and analysed using Fisher’s exact or Chi-square tests as appropriate. Mean ± SD and independent samples t tests were used to present and analyse the normally distributed continuous data, while skewed variables were presented as medians and analysed using the Mann–Whitney U test or median test. Answers in each HRQoL dimension were then regrouped into two categories only: no problem and presence of a problem with “some” and “extreme” answers combined. Univariate and multivariate logistic regression were performed to obtain crude and adjusted odds ratios and 95% confidence intervals for sex in each HRQoL dimension. Age, low-income, lower education, STEMI, hypertension, diabetes mellitus, hyperlipidemia, previous CABG, previous PCI, left main disease have been utilized for adjusting the differences in men and women. The HRQoL index scores were transformed due to highly skewed data and then back transformed to obtain the geometric means. To evaluate the effect size for the differences in VAS, Cohen’s D has been applied for crude model and epsilon has been utilized for the adjusted model. To assess the change in HRQoL from 30 days to 12 months between men and women at three states (get worse, no change and get better), a Mann Whitney U test was undertaken. All p values were two-tailed with statistical significance defined as p ≤ 0.05. All statistical analyses were conducted using SPSS Version 27.0 for Windows.

Results

Baseline and procedural characteristics

Characteristics of male and female patients are shown in Table 1. Of 866 patients, the proportion of women was less than half of men (32.1 vs. 67.9%). Compared with men, women were 3.5 years older, had a lower income and educational level, had a greater prevalence of previous cardiovascular risk factors but reported a lower prevalence of prior coronary artery revascularization as well as lesion in left main coronary artery (all p < 0.05).
Table 1
Baseline and procedural characteristics according to sex
 
Total (n = 866)
Women (n = 278)
Men (n = 588)
P*
Age (years), mean ± SD
67.60 ± 9.82
70.00 ± 9.03
66.46 ± 9.98
< 0.001
Low-incomea
648 (73.5)
235 (84.5)
413 (70.2)
< 0.001
Lower educationb
521 (59.1)
181 (65.1)
340 (57.8)
0.041
BMI (kg/m2), mean ± SD
22.24 ± 2.93
21.96 ± 3.09
22.37 ± 2.85
0.056
Presentation
    
 STEMI
114 (12.9)
27 (9.7)
87 (14.8)
0.039
 NSTEMI
136 (15.4)
47 (16.9)
89 (15.1)
0.504
 Unstable angina
214 (24.3)
74 (26.6)
140 (23.8)
0.371
 ACS
464 (52.6)
148 (53.2)
316 (53.7)
0.890
 Stable CAD
402 (45.6)
130 (46.8)
272 (46.3)
 
Medical history
    
 Hypertension
578 (65.5)
208 (74.8)
370 (62.9)
0.001
 Diabetes mellitus
238 (27.0)
94 (33.8)
144 (24.5)
0.004
 Hyperlipidaemia
270 (30.6)
106 (38.1)
164 (27.9)
0.002
 Prior cerebral vascular disease
121 (13.7)
38 (13.7)
83 (14.1)
0.860
 Current smoking
108 (12.2)
1 (33.3)
107 (25.6)
0.760
 Previous CABG
11 (1.2)
0 (0.0)
11 (1.9)
0.022
 Previous PCI
309 (35.0)
80 (28.8)
229 (38.9)
0.004
Tests prior to PCI
    
 Left ventricular ejection fraction ≤ 40%
86 (9.8)
24 (9.4)
62 (12.0)
0.292
 Moderate to severe renal impairment a
15 (1.7)
3 (1.1)
12 (2.1)
0.311
Procedural characteristics
    
 Radial access
685 (77.7)
220 (79.1)
465 (79.1)
0.985
 Left main disease
93 (10.5)
17 (6.1)
76 (12.9)
0.003
 Lesion type B2 and C
822 (93.2)
263 (94.6)
559 (95.1)
0.772
 ≥ 2 Stents per lesion
359 (40.7)
105 (37.8)
254 (43.2)
0.130
 PCI with ≥ 2 lesions
182 (20.6)
57 (20.5)
125 (21.3)
0.799
 Stent used
856 (97.1)
276 (99.3)
580 (98.6)
0.410
 Balloon used only
3 (0.3)
1 (0.4)
2 (0.3)
0.963
 Procedural success
860 (97.5)
277 (99.6)
583 (99.1)
0.416
 In hospital major bleeding
15 (1.7)
8 (2.9)
7 (1.2)
0.076
BMI body mass index, STEMI ST-elevation myocardial infraction, NSTEMI non-ST-elevation myocardial infraction, CABG coronary artery bypass grafts, PCI percutaneous coronary intervention
*Based on the χ2 test
aIndividual monthly income < 216 USD with the exchange rate of 23.150 VND
bEducation from primary to high school

30 days and 12 months quality of life post PCI

HRQoL of men and women are presented in Tables 2 and 3. At 30 days, over 80% of patients reported having no problem in mobility, personal care, and anxiety/depression, and more than 75% of them reported experiencing some problems in usual activity and moderate pain/discomfort (Table 2). Similarly, the proportions of patients without problems in mobility, personal care, usual activity and anxiety/depression were high (> 80%) at 12 months. Approximately two third of patients reported they had no pain/discomfort and one third reporting moderate pain/discomfort (Table 3). The geometric means of HRQoL index score at 30 days and 12 months are 0.780 (95% confidence interval: 0.770–0.790) and 0.866 (0.857–0.874), respectively. The means of VAS at 30 days and 12 months are 69.69 (68.08–69.31) and 72.49 (71.66–73.33), respectively. HRQoLAt 30 days, women were significantly more likely than men to report a problem in 3 dimensions of EQ-5D-3L. Specifically, women reported higher mobility problems relative to men (21.6% vs 11.6%), higher personal care problems (12.6% vs 7.0%,) and higher pain or discomfort compared to men (81.7% vs 79.8%). Women had significantly poorer mobility (adjusted OR 1.818, 95% CI 1.218–2.713, p = 0.003), higher personal care problems (adjusted OR 1.590, 95% CI 0.987–2.563, p = 0.057), and higher pain or discomfort experience (OR 1.574, 95% CI 1.022–2.425, p = 0.04) compared with men. In addition, the adjusted geometric means of HRQoL index score was lower in women (0.763 vs 0.788, p = 0.031), despite similar adjusted self-rate EQ-VAS score between men and women at 30 days.
Table 2
30-day quality of life (HRQoL) post PCI according to sex
Variable
Total, n (%)
Women, n (%)
Men, n (%)
Crude
Adjustedb
OR (95% CI)a
P value*
OR (95% CI)
P value*
HRQoL mobility
       
 No problem
731 (84.4)
216 (77.7)
515 (87.6)
1.00 (reference)
 
1.00 (reference)
 
 Some problem
128 (14.8)
60 (21.6)
68 (11.6)
2.025 (1.393–2.943)
< .001
1.818 (1.218–2.713)
0.003
 Unable to walk around
7 (0.8)
2 (0.7)
5 (0.9)
    
HRQoL personal care
       
 No problem
778 (89.9)
238 (85.6)
540 (91.8)
1.00 (reference)
 
1.00 (reference)
 
 Some problem
76 (8.8)
35 (12.6)
41 (7.0)
1.891 (1.210–2.955)
0.005
1.590 (0.987–2.563)
0.057
 Unable to wash/dress self
12 (1.4)
5 (1.8)
7 (1.2)
    
HRQoL usual activity
       
 No problem
179 (20.7)
48 (17.3)
131 (22.3)
1.00 (reference)
 
1.00 (reference)
 
 Some problem
667 (77.0)
221 (79.5)
446 (75.9)
1.374 (0.952–1.982)
0.09
1.193 (0.807–1.764)
0.377
 Unable to perform usual activities
20 (2.3)
9 (3.2)
11 (1.9)
    
HRQoL pain/discomfort
       
 No pain/discomfort
128 (14.8)
31 (11.2)
97 (16.5)
1.00 (reference)
 
1.00 (reference)
 
 Mod pain/discomfort
696 (80.4)
227 (81.7)
469 (79.8)
1.574 (1.022–2.425)
0.04
1.360 (0.860–2.153)
0.189
 Extreme pain/discomfort
42 (4.8)
20 (7.2)
22 (3.7)
    
HRQoL anxiety/depression
       
 No anxiety/depression
729 (84.2)
228 (82.0)
501 (85.2)
1.00 (reference)
 
1.00 (reference)
 
 Mod anxiety/depression
132 (15.2)
50 (18.0)
82 (13.9)
1.263 (0.862–1.849)
0.23
1.180 (0.786–1.772)
0.424
 Extreme anxiety/depression
5 (0.6)
0 (0.0)
5 (0.9)
    
HRQoL EQ-5D Index Score, geometric means (95% CI)
       
 Crude
0.780 (0.770–0.790)
0.755 (0.738–0.773)
0.792 (0.779–0.805)
 
0.001
  
 Adjustedb
NA
0.763 (0.744–0.781)
0.788 (0.775–0.801)
   
0.031
HRQoL own health state today (VAS), means (95% CI)
       
 Crude
69.69 (68.08–69.31)
68.26 (67.24–69.27)
69.77 (69.07–70.47)
 
0.016
  
 Adjustedb
NA
68.64 (67.60–69.67)
69.59 (68.89–70.28)
   
0.144
 Effect size
   
Cohen’s d: 0.175
 
ε2: 0.001
 
I confidence interval, OR odds ratio, NA not applicable, VAS visual analogue scale
*P for difference in point estimates between women and men based on multiple regression analysis
aThe main exposure was sex in which men were taken as the referent group; the outcome was each dimension of HRQoL, with a problem being defined as the combination of “some” and “extreme” category
bAdjusted for age, low-income, lower education, STEMI, hypertension, diabetes mellitus, hyperlipidemia, previous CABG, previous PCI, left main disease
Table 3
12 months quality of life (HRQoL) post PCI according to sex
Variable
Total, n (%)
Women, n (%)
Men, n (%)
Crude
Adjustedb
OR (95% CI)a
P value*
OR (95% CI)
P value*
HRQoL mobility
       
 No problem
731 (84.4)
232 (83.5)
499 (84.9)
1.112 (0.754–1.639)
0.593
0.95 (0.63–1.44)
0.820
 Some problem
132 (15.2)
45 (16.2)
87 (14.8)
    
 Unable to walk around
3 (0.3)
1 (0.4)
2 (0.3)
    
HRQoL personal care
       
 No problem
840 (97.0)
266 (95.7)
574 (97.6)
1.850 (0.844–4.054)
0.124
1.48 (0.63–3.47)
0.374
 Some problem
23 (2.7)
11 (4.0)
12 (2.0)
    
 Unable to wash/dress self
3 (0.3)
1 (0.4)
2 (0.3)
    
HRQoL usual activity
       
 No problem
705 (81.4)
217 (78.1)
488 (83.0)
1.372 (0.961–1.959)
0.082
1.48 (1.01–2.16)
0.046
 Some problem
157 (18.1)
60 (21.6)
97 (16.5)
    
 Unable to perform usual activities
4 (0.5)
1 (0.4)
3 (0.5)
    
HRQoL pain/discomfort
       
 No pain/discomfort
570 (65.8)
172 (61.9)
398 (67.7)
1.219 (0.959–1.738)
0.092
1.30 (0.94–1.78)
0.109
 Mod pain/discomfort
282 (32.6)
100 (36.0)
182 (31.0)
    
 Extreme pain/discomfort
14 (1.6)
6 (2.2)
8 (1.4)
    
HRQoL anxiety/depression
       
 No anxiety/depression
833 (96.2)
266 (95.7)
567 (96.4)
1.218 (0.590–2.513)
0.593
1.29 (0.60–2.78)
0.513
 Mod anxiety/depression
33 (3.8)
12 (4.3)
21 (3.6)
    
 Extreme anxiety/depression
0 (0.0)
0 (0.0)
0 (0.0)
    
HRQoL EQ-5D Index Score, geometric means (95% CI)
       
 Crude
0.866 (0.857–0.874)
0.856 (0.841–0.871)
0.870 (0.860–0.881)
 
0.12
  
 Adjustedb
NA
0.859 (0.844–0.874)
0.869 (0.859–0.879)
   
0.316
HRQoL own health state today (VAS), means (95% CI)
       
 Crude
72.49 (71.66–73.33)
70.77 (69.30–72.23)
73.31 (72.30–74.32)
 
0.005
  
 Adjustedb
NA
71.34 (69.83–72.85)
73.04 (72.02–74.06)
   
0.074
 Effect size
  
Cohen’s d: 0.204
 
ε2: 0.003
 
OR odds ratio, CI confidence interval, VAS visual analogue scale
*P for difference in point estimates between women and men based on multiple regression analysis
aThe main exposure was sex in which men were taken as the referent group; the outcome was each dimension of HRQoL, with a problem being defined as the combination of “some” and “extreme” category
bAdjusted for age, low-income, lower education, STEMI, hypertension, diabetes mellitus, hyperlipidemia, previous CABG, previous PCI, left main disease
At 12 months, women were also more likely than men to report a problem in all 5 dimensions of EQ-5D-3L. The differences were found significantly in usual activity when women reported more problem with daily activities than men (adjusted OR 1.48, 95% CI 1.01–2.16, p = 0.046). There were no differences found in the adjusted geometric mean of the HRQoL index score and VAS of men and women at 12 months.

Change in quality of life from 30 days to 12 months

Figure 1 presents the changes in the dimensions of the EQ-5D, the HRQoL index score and the EQ-Visual Analogue Scale (VAS). Over 75% patients reported their health status being unchanged from 30 days to 12 months with respect to mobility, personal care, and anxiety/depression. In performing usual activity and experience of pain/discomfort, approximately two third of patients reported better outcomes from 30 days to 12 months. The change in HRQoL index score and self-rate VAS indicated that the majority of patients reported better outcome at 12 months.
Compared with men, women were significantly more likely to recover better in mobility (18.3% vs 9.5%, p = 0.019), with a suggestion of better recovery for personal care (12.9% vs 7.0%, p = 0.061). There were no significant differences between men and women regarding the change in other dimensions (i.e., usual activity, pain/discomfort and anxiety/depression), or HRQoL index score and VAS (p > 0.05).

Discussion

This study is the first using PCI registry data at 30 days and 12 months to compare HRQoL after PCI between men and women in a low-and-middle income country where men are culturally more prioritized than women. The results indicated that women patients experienced poorer HRQoL after PCI in comparison with men. The differences were seen more clearly at 30 days than at 12 months post discharge, perhaps suggesting a higher recovery rate in the women patients. These findings contribute to the literature from developing countries in regard to HRQoL between men and women after an effective revascularization such as PCI. Further, they are potentially beneficial for defining an appropriate intervention strategy targeting patient outcomes after PCI in Vietnam. It appears that women are in greater need, particularly at 30 days suggesting that sex-specific health care approaches should be taken into consideration in providing care for PCI patients.
Available studies in literature that examined the sex differences in HRQoL outcome among PCI patients have utilized a range of HRQoL measurements. Using the same EQ-5D-3L instrument as our study, the Australian state-wide study including data from 30 cardiac centres reported poorer HRQoL outcome of women in comparison with men and confirmed being female was a significant predictor for poor HRQoL at 30 days [7]. In other studies using different HRQoL instruments such as Short-Form 12 questionnaire, 36-Items Short-Form Health Survey and the MacNew Heart Disease Health-Related QoL questionnaire, some reported general worse health condition in women [6, 12], while there were others indicating women were lower in specific areas of physical, disease-specific HRQoL and mental health [13, 29]. Findings in our study are consistent with previous findings regardless the HRQoL instruments, indicating that women had more problems in mobility, personal care and pain/discomfort at 30 days after PCI. In other studies that investigated the HRQoL outcomes between men and women after myocardial infarction or coronary artery diseases, similar results were documented. Women patients were more HRQoL disadvantaged than male counterparts at short and mid-terms such as 30 days, 1 year and 2.5 years [3032]. The available evidence suggested that HRQoL declines with the presence and intensity of cardiovascular risk factors such as hypertension, lipid metabolism disorders, diabetes, and sedentary lifestyle. It was also indicated that the more cardiovascular factors present at the same time, the worse the HRQoL score [6, 33]. Furthermore, older age was considered as an associated factor with low HRQoL scores due to the restrictions and difficulties in familial, social and professional life for the elderly [6]. Our results were consistent with these explanations, showing that women undergoing PCI were older, lower in education and income, and had significantly higher rates of cardiovascular risks in comparison with men counterparts. However, our study did not indicate the associated factors for worse HRQoL outcomes, more dedicated studies need to address this issue in future and more sex-specific health care programs should be implemented.
Studies regarding HRQoL of PCI populations have also documented no sex differences in long-term follow-up and have shown that women improved better than men in HRQoL over time. It was reported that HRQoL differences between men and women PCI patients were seen in short and mid-terms such as 1 months and 6 months but not for longer terms such as 3 years or 10 years [6, 12]. Similarly, a study of Włodarczyk showed men performed higher in the physical and emotional aspects of life at 2 and 3 months follow-ups after myocardial infarction, but not at 12 months assessment [34]. This finding was reinforced in our study with no statistically significant difference in HRQoL of the men and women at 12 months. Regarding the HRQoL improvement of patients post discharge, findings remain controversial in current literature. While both sexs reported significant improvement over time, women were more likely to have better recovery in HRQoL [6]. Another study concluded that women patients were reported with slower physical improvement compared to men [29]. In our study, women were found to have better recovery in mobility compared to men. The reason for this change remains unclear and further research should be conducted to investigate this issue further.
This study has some limitations. Our results may not be generalisable to the entire Vietnamese adults because this study was based on registry data collected from only one leading cardiac hospital in Vietnam. Given the hospital is a relatively advanced provider of cardiac intervention, it may be that the outcomes observed elsewhere might be worse, and hence flagging an even greater need for better follow-up care in this patient group. Another limitation is that we could not collect HRQoL before PCI, therefore could not conclude the effect of PCI on HRQoL change. This was because many of the patients were admitted as emergency cases, and there was not an opportunity to collect data prior to PCI. In addition, due to the lack of specific value set for the EQ-5D-3L derived from preferences of the Vietnamese population, the Malaysian value set was used to generate the index score due to the similarity between the two populations. We strongly encourage the development of a specific HRQoL value set for the Vietnamese population to increase the precision of results obtained. Lastly, although potential confounding factors were adjusted, the effect of unmeasured confounders and/or residual confounding cannot be ruled out. This may have obscured the relation between gender and QoL measures, if any.

Conclusion

Our study utilizing data from the first Vietnamese PCI registry provides an opportunity to investigate the sex differences in HRQoL post discharge. Overall, women obtained worse HRQoL after PCI in comparison with men. The differences were seen more clearly at 30 days than at 12 months post discharge, and women were reported to have better recovery in mobility compared to men.

Acknowledgements

We wish to thank the Victorian Cardiac Outcomes Registry for their kind agreement for the adoption of data collection materials, including the abstraction forms and definitions. We wish to also thank the Vietnam Nation Heart Institute for providing us with the opportunity to conduct the pilot registry and the facilities related to the study.

Declarations

Conflict of interest

The authors report no relationships that could be construed as a conflict of interest.
The protocol of this study was approved by the Curtin Human Research Ethics Committee (HRE 2017–0378). Patients did not provide the consent to participate but they were aware of the right to opt out from the study without any treatment impact.
Participants have the right to opt out from the study without any treatment impact.
Not applicable.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Onze productaanbevelingen

BSL Podotherapeut Totaal

Binnen de bundel kunt u gebruik maken van boeken, tijdschriften, e-learnings, web-tv's en uitlegvideo's. BSL Podotherapeut Totaal is overal toegankelijk; via uw PC, tablet of smartphone.

Bijlagen

Supplementary Information

Below is the link to the electronic supplementary material.
Literatuur
1.
go back to reference Gencer, B., Rodondi, N., Auer, R., Nanchen, D., Raber, L., Klingenberg, R., et al. (2016). Health utility indexes in patients with acute coronary syndromes. Open Heart, 3(1), e000419.CrossRef Gencer, B., Rodondi, N., Auer, R., Nanchen, D., Raber, L., Klingenberg, R., et al. (2016). Health utility indexes in patients with acute coronary syndromes. Open Heart, 3(1), e000419.CrossRef
2.
go back to reference Kwong, E., Neuburger, J., Petersen, S. E., & Black, N. (2019). Using patient-reported outcome measures for primary percutaneous coronary intervention. Open Heart, 6(1), e000920.CrossRef Kwong, E., Neuburger, J., Petersen, S. E., & Black, N. (2019). Using patient-reported outcome measures for primary percutaneous coronary intervention. Open Heart, 6(1), e000920.CrossRef
3.
go back to reference Yan, B. P., Chan, L. L. Y., Lee, V. W. Y., Yu, C. M., Wong, M. C. S., Sanderson, J., et al. (2018). Sustained 3-year benefits in quality of life after percutaneous coronary interventions in the elderly: a prospective cohort study. Value Health, 21(4), 423–431.CrossRef Yan, B. P., Chan, L. L. Y., Lee, V. W. Y., Yu, C. M., Wong, M. C. S., Sanderson, J., et al. (2018). Sustained 3-year benefits in quality of life after percutaneous coronary interventions in the elderly: a prospective cohort study. Value Health, 21(4), 423–431.CrossRef
4.
go back to reference Yinko, S. S. L. L., Pelletier, R., Behlouli, H., Norris, C. M., Humphries, K. H., Pilote, L., et al. (2014). Health-related quality of life in premature acute coronary syndrome: does patient sex or gender really matter? Journal of the American Heart Association, 3(4), e000901.CrossRef Yinko, S. S. L. L., Pelletier, R., Behlouli, H., Norris, C. M., Humphries, K. H., Pilote, L., et al. (2014). Health-related quality of life in premature acute coronary syndrome: does patient sex or gender really matter? Journal of the American Heart Association, 3(4), e000901.CrossRef
5.
go back to reference Karimi, M., & Brazier, J. (2016). Health, health-related quality of life, and quality of life: what is the difference? PharmacoEconomics, 34(7), 645–649.CrossRef Karimi, M., & Brazier, J. (2016). Health, health-related quality of life, and quality of life: what is the difference? PharmacoEconomics, 34(7), 645–649.CrossRef
6.
go back to reference Jankowska-Polanska, B., Uchmanowicz, I., Dudek, K., & Loboz-Grudzien, K. (2016). Sex differences in the quality of life of patients with acute coronary syndrome treated with percutaneous coronary intervention after a 3-year follow-up. Patient Preference and Adherence, 10, 1279–87.CrossRef Jankowska-Polanska, B., Uchmanowicz, I., Dudek, K., & Loboz-Grudzien, K. (2016). Sex differences in the quality of life of patients with acute coronary syndrome treated with percutaneous coronary intervention after a 3-year follow-up. Patient Preference and Adherence, 10, 1279–87.CrossRef
7.
go back to reference Koh, Y., Stehli, J., Martin, C., Brennan, A., Dinh, D. T., Lefkovits, J., et al. (2019). Does sex predict quality of life after acute coronary syndromes: an Australian, state-wide, multicentre prospective cohort study. BMJ Open, 9(12), e034034.CrossRef Koh, Y., Stehli, J., Martin, C., Brennan, A., Dinh, D. T., Lefkovits, J., et al. (2019). Does sex predict quality of life after acute coronary syndromes: an Australian, state-wide, multicentre prospective cohort study. BMJ Open, 9(12), e034034.CrossRef
8.
go back to reference Gijsberts, C. M., Agostoni, P., Hoefer, I. E., Asselbergs, F. W., Pasterkamp, G., Nathoe, H., et al. (2015). Gender differences in health-related quality of life in patients undergoing coronary angiography. Open Heart, 2(1), e000231.CrossRef Gijsberts, C. M., Agostoni, P., Hoefer, I. E., Asselbergs, F. W., Pasterkamp, G., Nathoe, H., et al. (2015). Gender differences in health-related quality of life in patients undergoing coronary angiography. Open Heart, 2(1), e000231.CrossRef
9.
go back to reference Norris, C. M., Murray, J. W., Triplett, L. S., & Hegadoren, K. M. (2010). Gender roles in persistent sex differences in health-related quality-of-life outcomes of patients with coronary artery disease. Gender Medicine, 7(4), 330–339.CrossRef Norris, C. M., Murray, J. W., Triplett, L. S., & Hegadoren, K. M. (2010). Gender roles in persistent sex differences in health-related quality-of-life outcomes of patients with coronary artery disease. Gender Medicine, 7(4), 330–339.CrossRef
10.
go back to reference Regitz-Zagrosek, V. (2012). Sex and gender differences in health. Science & society series on sex and science. EMBO Reports, 13(7), 596–603.CrossRef Regitz-Zagrosek, V. (2012). Sex and gender differences in health. Science & society series on sex and science. EMBO Reports, 13(7), 596–603.CrossRef
11.
go back to reference Tseng, J. (2008). Sex, gender, and why the differences matter. Virtual Mentor, 10(7), 427–428. Tseng, J. (2008). Sex, gender, and why the differences matter. Virtual Mentor, 10(7), 427–428.
12.
go back to reference Hartman, E. M. J., Dulfer, K., Utens, E. M. W. J., van den Berge, J. C., Daemen, J., & van Domburg, R. T. (2014). Gender differences in quality of life after PCI attenuate after a 10 year follow-up. International Journal of Cardiology, 176(3), 1176–1177.CrossRef Hartman, E. M. J., Dulfer, K., Utens, E. M. W. J., van den Berge, J. C., Daemen, J., & van Domburg, R. T. (2014). Gender differences in quality of life after PCI attenuate after a 10 year follow-up. International Journal of Cardiology, 176(3), 1176–1177.CrossRef
13.
go back to reference Sahakyan, Y. A. (2011). Gender differences in quality of life after percutaneous coronary intervention. New Armenian Medical Journal, 5(4), 33–37. Sahakyan, Y. A. (2011). Gender differences in quality of life after percutaneous coronary intervention. New Armenian Medical Journal, 5(4), 33–37.
14.
go back to reference Duenas, M., Ramirez, C., Arana, R., & Failde, I. (2011). Gender differences and determinants of health related quality of life in coronary patients: a follow-up study. BMC Cardiovascular Disorders, 11, 1–11.CrossRef Duenas, M., Ramirez, C., Arana, R., & Failde, I. (2011). Gender differences and determinants of health related quality of life in coronary patients: a follow-up study. BMC Cardiovascular Disorders, 11, 1–11.CrossRef
15.
go back to reference Emery, C. F., Frid, D. J., Engerbretson, T. O., Alonzo, A. A., Fish, A., Ferketich, A. K., et al. (2004). Gender differences in quality of life among cardiac patients. Psychosomatic Medicine, 66(2), 190–197.CrossRef Emery, C. F., Frid, D. J., Engerbretson, T. O., Alonzo, A. A., Fish, A., Ferketich, A. K., et al. (2004). Gender differences in quality of life among cardiac patients. Psychosomatic Medicine, 66(2), 190–197.CrossRef
16.
go back to reference Vu, T., Nguyen, T., Pham, M., Do, D., Nguyen, N., Norman, R., et al. (2020). Establishment of a percutaneous coronary intervention registry in Vietnam: rationale and methodology. Global Heart, 15(1), 30.CrossRef Vu, T., Nguyen, T., Pham, M., Do, D., Nguyen, N., Norman, R., et al. (2020). Establishment of a percutaneous coronary intervention registry in Vietnam: rationale and methodology. Global Heart, 15(1), 30.CrossRef
17.
go back to reference Vu, H. T. T., Pham, H. M., Nguyen, H. T. T., Nguyen, Q. N., Do, L. D., Pham, N. M., et al. (2020). Novel insights into clinical characteristics and in-hospital outcomes of patients undergoing percutaneous coronary intervention in Vietnam. IJC Heart & Vasculature, 31, 100626.CrossRef Vu, H. T. T., Pham, H. M., Nguyen, H. T. T., Nguyen, Q. N., Do, L. D., Pham, N. M., et al. (2020). Novel insights into clinical characteristics and in-hospital outcomes of patients undergoing percutaneous coronary intervention in Vietnam. IJC Heart & Vasculature, 31, 100626.CrossRef
18.
go back to reference Vu, H. T. T., Norman, R., Pham, N. M., Nguyen, H. T. T., Pham, H. M., Nguyen, Q. N., et al. (2021). Outcomes following the percutaneous coronary intervention in contemporary Vietnamese practice: insight from a single centre prospective cohort. Heart and Lung, 50(5), 634–639.CrossRef Vu, H. T. T., Norman, R., Pham, N. M., Nguyen, H. T. T., Pham, H. M., Nguyen, Q. N., et al. (2021). Outcomes following the percutaneous coronary intervention in contemporary Vietnamese practice: insight from a single centre prospective cohort. Heart and Lung, 50(5), 634–639.CrossRef
19.
go back to reference Vu, H. T. T., Norman, R., Pham, N. M., Pham, H. M., Nguyen, H. T. T., Nguyen, Q. N., et al. (2021). Access route selection for percutaneous coronary intervention among Vietnamese patients: Implications for in-hospital costs and outcomes. The Lancet Regional Health-Western Pacific, 9, 100116.CrossRef Vu, H. T. T., Norman, R., Pham, N. M., Pham, H. M., Nguyen, H. T. T., Nguyen, Q. N., et al. (2021). Access route selection for percutaneous coronary intervention among Vietnamese patients: Implications for in-hospital costs and outcomes. The Lancet Regional Health-Western Pacific, 9, 100116.CrossRef
20.
go back to reference Yeoh, J., Yudi, M. B., Andrianopoulos, N., Yan, B. P., Clark, D. J., Duffy, S. J., et al. (2017). Evolution of Australian Percutaneous Coronary Intervention (from the Melbourne Interventional Group [MIG] Registry). American Journal of Cardiology, 120(1), 47–54.CrossRef Yeoh, J., Yudi, M. B., Andrianopoulos, N., Yan, B. P., Clark, D. J., Duffy, S. J., et al. (2017). Evolution of Australian Percutaneous Coronary Intervention (from the Melbourne Interventional Group [MIG] Registry). American Journal of Cardiology, 120(1), 47–54.CrossRef
21.
go back to reference Stub, D., Lefkovits, J., Brennan, A. L., Dinh, D., Brien, R., Duffy, S. J., et al. (2018). The establishment of the victorian cardiac outcomes registry (VCOR): monitoring and optimising outcomes for cardiac patients in Victoria. Heart, Lung & Circulation, 27(4), 451–463.CrossRef Stub, D., Lefkovits, J., Brennan, A. L., Dinh, D., Brien, R., Duffy, S. J., et al. (2018). The establishment of the victorian cardiac outcomes registry (VCOR): monitoring and optimising outcomes for cardiac patients in Victoria. Heart, Lung & Circulation, 27(4), 451–463.CrossRef
22.
go back to reference EuroQol, G. (1990). EuroQol—A new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208.CrossRef EuroQol, G. (1990). EuroQol—A new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208.CrossRef
23.
go back to reference Yusof, F. A. M., Goh, A., & Azmi, S. (2012). Estimating an EQ-5D value set for Malaysia using time trade-off and visual analogue scale methods. Value Health, 15(1), S85–S90.CrossRef Yusof, F. A. M., Goh, A., & Azmi, S. (2012). Estimating an EQ-5D value set for Malaysia using time trade-off and visual analogue scale methods. Value Health, 15(1), S85–S90.CrossRef
24.
go back to reference Thygesen, K., Alpert, J. S., Jaffe, A. S., Simoons, M. L., Chaitman, B. R., White, H. D., et al. (2012). Third universal definition of myocardial infarction. Global Heart, 7(4), 275–295.CrossRef Thygesen, K., Alpert, J. S., Jaffe, A. S., Simoons, M. L., Chaitman, B. R., White, H. D., et al. (2012). Third universal definition of myocardial infarction. Global Heart, 7(4), 275–295.CrossRef
25.
go back to reference Victorian Cardiac Outcomes Registry. (2005). Data definitions—Percutaneous coronary intervntion Victoria. Victorian Cardiac Outcomes Registry. (2005). Data definitions—Percutaneous coronary intervntion Victoria.
26.
go back to reference Sianos, G., Morel, M. A., Kappetein, A. P., Morice, M. C., Colombo, A., Dawkins, K., et al. (2005). The SYNTAX Score: An angiographic tool grading the complexity of coronary artery disease. EuroIntervention, 1(2), 219–227. Sianos, G., Morel, M. A., Kappetein, A. P., Morice, M. C., Colombo, A., Dawkins, K., et al. (2005). The SYNTAX Score: An angiographic tool grading the complexity of coronary artery disease. EuroIntervention, 1(2), 219–227.
27.
go back to reference Levine, G. N., Bates, E. R., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., et al. (2016). 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation, 133(11), 1135–1147.CrossRef Levine, G. N., Bates, E. R., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., et al. (2016). 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation, 133(11), 1135–1147.CrossRef
28.
go back to reference Mehran, R., Rao, S. V., Bhatt, D. L., Gibson, C. M., Caixeta, A., Eikelboom, J., et al. (2011). Standardized bleeding definitions for cardiovascular clinical trials: A consensus report from the Bleeding Academic Research Consortium. Circulation, 123(23), 2736–2747.CrossRef Mehran, R., Rao, S. V., Bhatt, D. L., Gibson, C. M., Caixeta, A., Eikelboom, J., et al. (2011). Standardized bleeding definitions for cardiovascular clinical trials: A consensus report from the Bleeding Academic Research Consortium. Circulation, 123(23), 2736–2747.CrossRef
29.
go back to reference Oreel, T. H., Nieuwkerk, P. T., Hartog, I. D., Netjes, J. E., Vonk, A. B. A., Lemkes, J., et al. (2020). Gender differences in quality of life in coronary artery disease patients with comorbidities undergoing coronary revascularization. Plos One, 15(6), e0234543.CrossRef Oreel, T. H., Nieuwkerk, P. T., Hartog, I. D., Netjes, J. E., Vonk, A. B. A., Lemkes, J., et al. (2020). Gender differences in quality of life in coronary artery disease patients with comorbidities undergoing coronary revascularization. Plos One, 15(6), e0234543.CrossRef
30.
go back to reference Pettersen, K. I., Reikvam, A., Rollag, A., & Stavem, K. (2008). Understanding sex differences in health-related quality of life following myocardial infarction. International Journal of Cardiology, 130(3), 449–456.CrossRef Pettersen, K. I., Reikvam, A., Rollag, A., & Stavem, K. (2008). Understanding sex differences in health-related quality of life following myocardial infarction. International Journal of Cardiology, 130(3), 449–456.CrossRef
31.
go back to reference Norris, C. M., Spertus, J. A., Jensen, L., Johnson, J., Hegadoren, K. M., Ghali, W. A., et al. (2008). Sex and gender discrepancies in health-related quality of life outcomes among patients with established coronary artery disease. Circulation: Cardiovascular Quality and Outcomes, 1(2), 123–130. Norris, C. M., Spertus, J. A., Jensen, L., Johnson, J., Hegadoren, K. M., Ghali, W. A., et al. (2008). Sex and gender discrepancies in health-related quality of life outcomes among patients with established coronary artery disease. Circulation: Cardiovascular Quality and Outcomes, 1(2), 123–130.
32.
go back to reference Garavalia, L. S., Decker, C., Reid, K. J., Lichtman, J. H., Parashar, S., Vaccarino, V., et al. (2007). Does health status differ between men and women in early recovery after myocardial infarction? Journal of Women’s Health, 16(1), 93–101.CrossRef Garavalia, L. S., Decker, C., Reid, K. J., Lichtman, J. H., Parashar, S., Vaccarino, V., et al. (2007). Does health status differ between men and women in early recovery after myocardial infarction? Journal of Women’s Health, 16(1), 93–101.CrossRef
33.
go back to reference Souza, E. N., Quadros, A. S., Maestri, R., Albarran, C., & Sarmento-Leite, R. (2008). Predictors of quality of life change after an acute coronary event. Arquivos Brasileiros de Cardiologia, 91(4), 229–235. Souza, E. N., Quadros, A. S., Maestri, R., Albarran, C., & Sarmento-Leite, R. (2008). Predictors of quality of life change after an acute coronary event. Arquivos Brasileiros de Cardiologia, 91(4), 229–235.
34.
go back to reference Wlodarczyk, D. (2016). Gender and quality of life and coping over one year after myocardial infarction: Do men really have the upper hand? Kardiologia Polska, 74(5), 447–453.CrossRef Wlodarczyk, D. (2016). Gender and quality of life and coping over one year after myocardial infarction: Do men really have the upper hand? Kardiologia Polska, 74(5), 447–453.CrossRef
Metagegevens
Titel
Sex differences in quality of life of patients following percutaneous coronary intervention in Vietnam
Auteurs
Hoa Vu
Richard Norman
Ngoc M. Pham
Hoai T. T. Nguyen
Hung M. Pham
Quang N. Nguyen
Loi D. Do
Christopher M. Reid
Publicatiedatum
29-08-2022
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 1/2023
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-022-03237-5

Andere artikelen Uitgave 1/2023

Quality of Life Research 1/2023 Naar de uitgave